Genpact Limited vs STANTEC INC., two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where G and STN diverge most: on debt / equity, G reads 0.46 and STN reads 0.00; on revenue growth, G reads +6.5% and STN reads +15.6%. The rest of the comparable metrics sit closer together. What G's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | G | STN |
|---|---|---|
| Price | $35.12 | $69.67 |
| Market cap | $6.0B | $7.9B |
| Sector | Consulting | Consulting |
| Stage | Mature | Growth |
| Implied growth (priced in) | — | +4.0% |
| P/E | 10.4 | 22.6 |
| P/B | 2.30 | 3.34 |
| P/S | 1.14 | 1.33 |
| EV/EBITDA | 8.4 | — |
| Revenue growth | +6.5% | +15.6% |
| Gross margin | 36.5% | — |
| Operating margin | 14.4% | — |
| Net margin | 11.1% | 5.9% |
| Return on equity | 22.4% | 14.8% |
| Return on assets | 10.8% | 6.0% |
| Return on invested capital | 15.6% | — |
| FCF yield | 9.6% | 8.0% |
| Dividend yield | 1.9% | — |
| Debt / equity | 0.46 | 0.00 |
| Current ratio | 2.00 | 1.23 |
| Altman Z (solvency) | 2.99 | 2.48 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.